Bismillah, alhamdulillah: Interesting article on how complex pricing strategies by modern pharmaceutical companies are being used to keep overall prices of medication high with ‘authorised’ generics.
Pharmaceutical companies with a brand name coming to the end of its patent period launch their own generic, an ‘authorised’ generic. The overall effect of these authorised generics is to prevent true generic drug manufacturers from getting a foothold in the market. Inadequate market penetration by cheaper true generic manufacturers allows the brand pharma to dictate prices, keep costs relatively higher and profits up. It makes you wonder how widespread this practice is.
Read more at Medscape.